Gemma Gatta
A5003169705- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Multiple and Secondary Primary Cancers
- Childhood Cancer Survivors' Quality of Life
- Acute Lymphoblastic Leukemia research
- Genetic factors in colorectal cancer
- Cancer Risks and Factors
- Economic and Financial Impacts of Cancer
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Neuroendocrine Tumor Research Advances
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Neuroblastoma Research and Treatments
- Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- BRCA gene mutations in cancer
- Colorectal Cancer Surgical Treatments
- Lymphoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Ovarian cancer diagnosis and treatment
- Sarcoma Diagnosis and Treatment
- Occupational and environmental lung diseases
- Tumors and Oncological Cases
- Salivary Gland Tumors Diagnosis and Treatment
Fondazione IRCCS Istituto Nazionale dei Tumori
2016-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2002-2024
Italian Association for Cancer Research
2022
Institut Català d'Oncologia
2015-2021
Institut d'Investigació Biomédica de Bellvitge
2021
Institut Curie
2018
Tumori Foundation
2017
Laboratoire de Biométrie et Biologie Evolutive
2017
Royal Marsden NHS Foundation Trust
2017
Government of Catalonia
2015
Cancer survival varies widely between countries. The CONCORD study provides estimates for 1.9 million adults (aged 15-99 years) diagnosed with a first, primary, invasive cancer of the breast (women), colon, rectum, or prostate during 1990-94 and followed up to 1999, by use individual tumour records from 101 population-based registries in 31 countries on five continents. This is, our knowledge, first worldwide analysis survival, standard quality-control procedures identical analytic methods...
BACKGROUND Only recently have extensive population-based cancer survival data become available in Europe, providing an opportunity to compare Europe and the United States. METHODS The authors considered 12 cancers: lung, breast, stomach, colon, rectum, melanoma, cervix uteri, corpus ovary, prostate, Hodgkin disease, non-Hodgkin lymphoma. analyzed 738,076 European 282,398 U.S. patients, whose disease was diagnosed 1985–1989, obtained from 41 EUROCARE registries 17 countries 9 SEER registries....
Global inequalities in access to health care are reflected differences cancer survival. The CONCORD programme was designed assess worldwide and trends population-based In this study, we aimed estimate survival globally for several subtypes of childhood leukaemia. Cancer registries participating were asked submit tumour registrations all children aged 0-14 years who diagnosed with leukaemia between Jan 1, 1995, Dec 31, 2009, followed up until 2009. Haematological malignancies defined by...
EUROCARE collected data from population-based cancer registries in 20 European countries. We used this to compare childhood survival time trends Europe.Survival 44,129 children diagnosed under the age of 15 years during 1983 1994 was analyzed. Sex- and age-adjusted 5-year for 10 common cancers all combined were estimated five regions (West Germany, United Kingdom, Eastern Europe, Nordic countries, West South Europe) Europe as a whole. Europe-wide 14 rare estimated.For combined, increased 65%...
BACKGROUND Marked differences in population based survival across Europe were found for colorectal cancers diagnosed 1985–1989. AIMS To understand the reasons these a new analysis of between 1988 and 1991. SUBJECTS A total 2720 patients with adenocarcinoma large bowel from 11 European cancer registries (CRs). METHODS We obtained information on stage at diagnosis, diagnostic determinants, surgical treatment (not routinely collected by CRs) analysed data relation to three year observed...
Abstract BACKGROUND Survival rates for most major adult cancers are higher in the United States compared with survival Europe. The objective of this study was to determine whether transatlantic differences also present childhood cancers. METHODS authors analyzed 16,148 European patients and 3476 who were diagnosed malignant disease at age < 15 years during 1985–1989. obtained from 34 EUROCARE cancer registries 17 countries 9 SEER States. considered 14 diagnostic categories International...